Test Code LAB4775 GROUP B STREP PCR
Infectious
Specimen Type
Eswab (liquid Amies)
- Vaginal/Rectal Specimen
Collection Instructions
Swab both the lower vagina and rectum (through the anal sphincter). Sampling both sites increases detection of colonization substantially compared with sampling the cervix or the vagina without also swabbing the rectum. (May 1, 2025 CDC recommendations) Clinical Guidelines for Group B Strep Disease).
Turnaround Time
24-48 hours
Test Schedule
Daily
Specimen Stability
Room temperature (15-30 °C ) for up to 24 hours
Refrigerated (2-8 °C) for up to 48 hours
Method
Cepheid GeneXpert Real-time PCR assay
Reference Ranges
Group B Strep by PCR: Detected*
Group B Strep by PCR: Not Detected
Group B Strep by PCR: Indeterminant*
*Pencillin-allergic patients that are positive for Group B Strep will automatically reflex to Group B Strep culture for susceptibility testing. Indeterminant results will also reflex to culture.
Synonyms
GBS PCR; Group B Strep; Strep Screen: Beta-Hemolytic Streptococcus; Streptococcus Group B; GBS; Culture, Beta Strep B Screen; Strep B; Strep B Screen
Test Components
Streptococcus, group B, amplified probe technique
CPT Codes
87150
Interfering Substances
Potentially interfering endogenous and exogenous substances include human amniotic fluid, urine, human blood, vaginal antifungal medications, anti- diarrheal medications, laxatives, stool softeners, topical hemorrhoid ointments, and deodorant sprays.
Specimen Rejection Criteria
- Incorrect or expired transport medium
- Any specimen that has leaked
- Improper storage conditions during transport
- Improper sample collection
Limitations
- Culture test results may be affected by concurrent antibiotic therapy. GBS DNA may continue to be detected following antimicrobial therapy.
- A positive result does not necessarily indicate the presence of viable organisms.
- Mutations or polymorphisms in primer or probe binding regions may affect detection of new or unknown variants and may result in a false negative result.